Children manifesting soft-tissue fungal infections are uncommonly seen, more so the subgroup of invasive soft-tissue mucormycosis. Invasive fungal infections in various organs respond differently and are often complicated by an immune-compromised host. Repeated and aggressive clearance of disease till an infection-clear margin is obtained is the mainstay of surgical therapy. This is coupled with appropriate antifungal therapy and the management of any underlying medical conditions. From our experience, we propose a surgical algorithm for therapy of soft-tissue mucormycosis in children.
HibbettDSBinderMBischoffJF, et al.A higher-level phylogenetic classification of the Fungi. Mycol Res2007; 111: 509–547.
2.
TheelESDoernCD. Beta-D-glucan testing is important for diagnosis of invasive fungal infections. J Clin Microbiol2013; 51: 3478–3483.
3.
De VliegerGLagrouKMaertensJ, et al.Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study. J Clin Microbiol2011; 49: 3783–3787.
4.
SkiadaALanternierFGrollAH, et al.Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica2013; 98: 492–504.
5.
SravaniTUppinSGUppinMS, et al.Rhinocerebral mucormycosis: Pathology revisited with emphasis on perineural spread. Neurol India2014; 62: 383–386.
6.
RodenMMZaoutisTEBuchananWL, et al.Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis2005; 41: 634–653.
7.
PanaZDSeidelDSkiadaA, et al.Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries. BMC Infect Dis2016; 16: 667–667.
8.
FrancisJRVillanuevaPBryantP, et al.Mucormycosis in children: review and recommendations for management. J Pediatric Infect Dis Soc2018; 7: 159–164.
9.
PaganoLCornelyOABuscaA, et al.Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FungiScope registries. Haematologica2013; 98: 127–130.
10.
KyvernitakisATorresHAJiangY, et al.Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis. Clin Microbiol Infect2016; 22: 811.e18–8.
11.
VironneauPKaniaRMorizotG, et al.Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival. Clin Microbiol Infect2014; 20: O336–339.
